PATENT CLAIM ANALYSIS

Application Number: 16389355
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "157000"]

Abstract:
The present invention provides compounds useful for treating or preventing a brain-related disease or disorder. The present invention further provides a method of treating or preventing a brain-related disease or disorder in a patient, comprising administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of modulating the activity of a monoamine transporter.

Claim (Index 19):
A method of inducing a conformational change in a monoamine transporter, the method comprising contacting the monoamine transporter with an effective amount of at least one compound of  claim 1 , whereby a conformational change is induced in the monoamine transporter.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 100.0
- Lexical Diversity: 1.97143
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15382002', '14784536', '14772486', '15830244', '12598882']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8024352136230497
- 35 USC 102 Novelty (BERT): 0.6441898567849945
- Combined Prediction Score: 0.7866106779392442
- Mean Citation Score: 440.32968199999993
- Max Citation Score: 696.1560000000003
- Similarity Product: 557.6023659653665

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test